Mount Sinai specialists debut AI and machine learning models targeting prediction and screening for severe pregnancy complications using imaging and EMR data at SMFM 2026.
Key Details
- 1AI-assisted tools for diagnosis of severe congenital heart defects from fetal scans presented.
- 2Machine learning models using EMR data can preconceptionally predict placenta accreta spectrum with high sensitivity and specificity.
- 3Novel risk factors for placenta accreta, including anemia, identified by the AI models.
- 4AI is being tested for real-world impact on completion rates of fetal cardiac screening at a prenatal ultrasound center.
- 5Research highlights the strong early evidence and potential clinical value of these AI approaches in maternal-fetal medicine.
Why It Matters
These advances suggest AI and machine learning could become critical in early identification and risk stratification of pregnancy complications, potentially improving prenatal care through better screening and management. This intersection between AI, imaging, and obstetric care exemplifies the growing clinical utility of radiology/AI collaboration.
Source
EurekAlert
Related News
•EurekAlert
FDA Approves Johns Hopkins AI Tool for Early Sepsis Detection
FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
•EurekAlert
New AI Vision-Language Model Enhances Chest CT Diagnostics
Researchers developed an interpretable AI model that uses visual question answering to generate detailed diagnostic findings from chest CT scans, aimed at improving lung cancer diagnosis.
•EurekAlert
Optical AI Chip Boosts Real-Time Dry Eye Gland Diagnosis Accuracy
A new metasurface spectral AI chip enables rapid, accurate diagnosis of meibomian gland dysfunction (MGD) from tissue samples, achieving 96.22% accuracy.